4583

Chiome Bioscience
4583

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
¥8.71B
EV
¥7.49B
Shares Outstanding
68.04M
Beta
0.30
Industry
Biotechnology

Wall Street View

Analyst Rating
-
Analyst Target Price
-
Number of Analysts
0
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Chiome Bioscience Inc.

gainify
4583

Chiome Bioscience Inc.

4583

Chiome Bioscience Inc. engages in the research and development of drug discovery technology platforms worldwide. The company operates through two segments, Drug Discovery Business and Drug Discovery Support Business. It offers ADLib System, a monoclonal antibody gener...

Sector

Healthcare

Industry

Biotechnology

CEO

Kobayashi, Shigeru

Employees

53

IPO Date

2011-12-20

Headquarters

Sumitomo Fudosan Nishi-shinjuku Bldg.No.6, 3-12-1 Honmachi, Shibuya-ku, Tokyo 151-0071, Japan

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.